Cargando…
Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genet...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471477/ https://www.ncbi.nlm.nih.gov/pubmed/34572768 http://dx.doi.org/10.3390/cancers13184541 |
_version_ | 1784574476032147456 |
---|---|
author | Tsesmelis, Miltiadis Tiwary, Kanishka Steiger, Katja Sperb, Nadine Gerstenlauer, Melanie Manfras, Uta Maier, Harald J. Hermann, Patrick C. Chan, Lap Kwan Wirth, Thomas |
author_facet | Tsesmelis, Miltiadis Tiwary, Kanishka Steiger, Katja Sperb, Nadine Gerstenlauer, Melanie Manfras, Uta Maier, Harald J. Hermann, Patrick C. Chan, Lap Kwan Wirth, Thomas |
author_sort | Tsesmelis, Miltiadis |
collection | PubMed |
description | SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genetically modified KPC mouse model. In the absence of NEMO, KPC mice exhibited extended survival, which was accompanied by a strong reduction in the development of liver metastasis and ascites. Our study provides evidence for a detrimental role of the conventional NF-κB pathway in the survival of KPC mice and underlines the fact that NF-κB could be a therapeutic target against PDAC. ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) remains a largely incurable cancer type. Its high mortality is attributed to the lack of efficient biomarkers for early detection combined with its high metastatic properties. The aim of our study was to investigate the role of NF-κB signaling in the development and metastasis of PDAC. We used the well-established KPC mouse model, and, through genetic manipulation, we deleted NF-κB essential modulator (NEMO) in the pancreata of KPC mice. Interestingly, NEMO deletion altered the differentiation status of the primary tumor but did not significantly affect its development. However, in the absence of NEMO, the median survival of the mice was prolonged by 13.5 days (16%). In addition, examination of the liver demonstrated that, whereas KPC mice occasionally developed liver macro-metastasis, NEMO deletion completely abrogated this outcome. Further analysis of the tumor revealed that the expression of epithelial–mesenchymal transition (EMT) transcription factors was diminished in the absence of NEMO. Conclusively, our study provides evidence that NF-κB is dispensable for the progression of high-grade PanINs towards PDAC. In contrast, NF-κB signaling is essential for the development of metastasis by regulating the gene expression program of EMT. |
format | Online Article Text |
id | pubmed-8471477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84714772021-09-28 Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice Tsesmelis, Miltiadis Tiwary, Kanishka Steiger, Katja Sperb, Nadine Gerstenlauer, Melanie Manfras, Uta Maier, Harald J. Hermann, Patrick C. Chan, Lap Kwan Wirth, Thomas Cancers (Basel) Article SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genetically modified KPC mouse model. In the absence of NEMO, KPC mice exhibited extended survival, which was accompanied by a strong reduction in the development of liver metastasis and ascites. Our study provides evidence for a detrimental role of the conventional NF-κB pathway in the survival of KPC mice and underlines the fact that NF-κB could be a therapeutic target against PDAC. ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) remains a largely incurable cancer type. Its high mortality is attributed to the lack of efficient biomarkers for early detection combined with its high metastatic properties. The aim of our study was to investigate the role of NF-κB signaling in the development and metastasis of PDAC. We used the well-established KPC mouse model, and, through genetic manipulation, we deleted NF-κB essential modulator (NEMO) in the pancreata of KPC mice. Interestingly, NEMO deletion altered the differentiation status of the primary tumor but did not significantly affect its development. However, in the absence of NEMO, the median survival of the mice was prolonged by 13.5 days (16%). In addition, examination of the liver demonstrated that, whereas KPC mice occasionally developed liver macro-metastasis, NEMO deletion completely abrogated this outcome. Further analysis of the tumor revealed that the expression of epithelial–mesenchymal transition (EMT) transcription factors was diminished in the absence of NEMO. Conclusively, our study provides evidence that NF-κB is dispensable for the progression of high-grade PanINs towards PDAC. In contrast, NF-κB signaling is essential for the development of metastasis by regulating the gene expression program of EMT. MDPI 2021-09-10 /pmc/articles/PMC8471477/ /pubmed/34572768 http://dx.doi.org/10.3390/cancers13184541 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tsesmelis, Miltiadis Tiwary, Kanishka Steiger, Katja Sperb, Nadine Gerstenlauer, Melanie Manfras, Uta Maier, Harald J. Hermann, Patrick C. Chan, Lap Kwan Wirth, Thomas Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice |
title | Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice |
title_full | Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice |
title_fullStr | Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice |
title_full_unstemmed | Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice |
title_short | Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice |
title_sort | deletion of nemo inhibits emt and reduces metastasis in kpc mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471477/ https://www.ncbi.nlm.nih.gov/pubmed/34572768 http://dx.doi.org/10.3390/cancers13184541 |
work_keys_str_mv | AT tsesmelismiltiadis deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT tiwarykanishka deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT steigerkatja deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT sperbnadine deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT gerstenlauermelanie deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT manfrasuta deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT maierharaldj deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT hermannpatrickc deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT chanlapkwan deletionofnemoinhibitsemtandreducesmetastasisinkpcmice AT wirththomas deletionofnemoinhibitsemtandreducesmetastasisinkpcmice |